Form D Explorer

Inspect source fieldsReport a record issue

Form D — Mati Therapeutics Inc.

0001574251-25-000002 · filed Sep 23, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
Rule 506(b)
Reported offering amount
$2,184,175
Reported amount sold
$2,184,175
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Mati Therapeutics Inc.
CIK
1574251
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
101 Colorado Street
AUSTIN, Texas 78701
Phone
512-720-1333

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗